highperformr logo

Momenta Pharmaceuticals's Overview

Total employees76
HeadquartersCambridge
Founded

Momenta Pharmaceuticals, Inc. was a biotechnology company focused on the discovery, development, and commercialization of novel biologic therapeutics for rare, immune-mediated diseases. Headquartered in Cambridge, Massachusetts, Momenta was known for its expertise in understanding the structural attributes of complex molecules to develop differentiated medicines. In October 2020, Momenta Pharmaceuticals was acquired by Johnson & Johnson for approximately $6.5 billion, and its operations and pipeline were integrated into Janssen Pharmaceutical Companies of Johnson & Johnson. Prior to its acquisition, Momenta was advancing a pipeline of drug candidates in hematology, neurology, and autoimmune diseases.

Where is Momenta Pharmaceuticals's Headquarters?

HQ Function

The headquarters served as the primary center for research and development, corporate operations, and strategic decision-making for Momenta Pharmaceuticals before its acquisition.

Notable Features:

Located in Kendall Square, a dense cluster of biotech and pharmaceutical companies, offering state-of-the-art laboratory and office spaces conducive to scientific innovation.

Work Culture:

Prior to acquisition, the work culture was likely characterized by scientific rigor, innovation, collaboration, and a strong focus on developing treatments for patients with unmet medical needs, typical of a mission-driven biotech company.

HQ Significance:

Its Cambridge location was significant due to the proximity to leading academic institutions (like MIT and Harvard), research hospitals, and a rich talent pool, fostering collaborations and innovation in the life sciences sector.

Values Reflected in HQ: The headquarters likely reflected values such as scientific excellence, innovation, and a commitment to advancing medical treatments through its design and facilities geared towards cutting-edge research.

Location:

Prior to its acquisition by Johnson & Johnson, Momenta Pharmaceuticals' operations were primarily based in the United States, with its headquarters in Cambridge, MA, serving as the hub for its research, development, and corporate functions. Its global reach was mainly through clinical trials conducted in various countries to support its drug development programs and through potential collaborations or partnerships. Post-acquisition, its assets and programs became part of Johnson & Johnson's extensive global R&D and commercial network.

Street Address:

250 First Avenue

City:

Cambridge

State/Province:

MA

Country:

USA

Momenta Pharmaceuticals's Global Presence

Buying Intent Signals for Momenta Pharmaceuticals

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Momenta Pharmaceuticals

As of April 2025, Momenta Pharmaceuticals' leadership includes:

Craig A. Wheeler - Former President and Chief Executive Officer
Young Kwon - Former Chief Financial and Business Officer
Anthony M. Manning, Ph.D. - Former Chief Scientific Officer
Santiago Arroyo, M.D., Ph.D. - Former Chief Medical Officer
Joanne C. Beck, Ph.D. - Former Senior Vice President, Pharmaceutical Sciences and Chief Operating Officer
Aleksandar Zivanovic, Ph.D. - Former Vice President, Chief Intellectual Property Counsel

Investors of Momenta Pharmaceuticals

Momenta Pharmaceuticals has been backed by several prominent investors over the years, including:

MPM Capital
Polaris Partners
Flagship Pioneering
Various public institutional investors (post-IPO, e.g., BlackRock, Vanguard)

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits6

Following the announcement and completion of Momenta Pharmaceuticals' acquisition by Johnson & Johnson in late 2020, the existing executive team largely transitioned out of their roles at Momenta as the company was integrated into J&J. Most changes occurred around October 2020.

Departures

Craig A. Wheeler, Departed as President and CEO following the acquisition by Johnson & Johnson.
Young Kwon, Departed as CFBO following the acquisition by Johnson & Johnson.
Anthony M. Manning, Ph.D., Departed as CSO following the acquisition by Johnson & Johnson.
Santiago Arroyo, M.D., Ph.D., Departed as CMO following the acquisition by Johnson & Johnson.
Joanne C. Beck, Ph.D., Departed following the acquisition by Johnson & Johnson.
Aleksandar Zivanovic, Ph.D., Departed following the acquisition by Johnson & Johnson.

Technology (Tech Stack) used by Momenta Pharmaceuticals

Discover the tools Momenta Pharmaceuticals uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Momenta Pharmaceuticals Email Formats and Examples

Prior to its acquisition by Johnson & Johnson, Momenta Pharmaceuticals likely used a common corporate email format, such as first initial followed by last name. As the company is now part of Johnson & Johnson and the momentapharma.com domain is inactive, these email formats are no longer in use.

[first_initial][last]@momentapharma.com

Format

jdoe@momentapharma.com

Example

0%

Success rate

News and media

Johnson & JohnsonOctober 1, 2020

Momenta Pharmaceuticals news title: Johnson & Johnson Completes Acquisition of Momenta Pharmaceuticals, Inc.

Johnson & Johnson announced it has successfully completed its acquisition of Momenta Pharmaceuticals, Inc., a company that discovers and develops novel biologic therapeutics for rare immune-mediated diseases. Momenta's stockholders approved the transaction, for which J&J paid $6.5 billion in an all-cash deal. Momenta's pipeline, including nipocalimab, will now be part of Janssen Pharmaceutical Companies....more

PR NewswireAugust 19, 2020

Momenta Pharmaceuticals news title: Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc.

Johnson & Johnson and Momenta Pharmaceuticals, Inc. announced they have entered into a definitive agreement for J&J to acquire Momenta for $52.50 per share in an all-cash transaction, representing a total equity value of approximately $6.5 billion. The acquisition will provide Janssen with an opportunity to broaden its leadership in immune-mediated diseases and drive further growth....more

GlobeNewswireJuly 29, 2020

Momenta Pharmaceuticals news title: Momenta Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Momenta Pharmaceuticals reported its financial results for the second quarter ending June 30, 2020, highlighting progress in its clinical programs, including nipocalimab for multiple indications. The company also provided updates on its research pipeline and corporate activities prior to the acquisition announcement....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Momenta Pharmaceuticals, are just a search away.